Glatiramer acetate for multiple sclerosis
41 results
1 - 41
Glatiramer acetate for multiple sclerosis
Glatiramer acetate for multiple sclerosis - Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis
- Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis
- Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis
- Immunomodulators and immunosuppressants for multiple sclerosis: a network meta‐analysis
- Natalizumab for relapsing remitting multiple sclerosis
- Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta‐analysis
- Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis
- Alemtuzumab for multiple sclerosis
- Azathioprine for multiple sclerosis
- Sodium channel blockers for neuroprotection in multiple sclerosis
- Rituximab for people with multiple sclerosis
- Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
- Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis
- Alemtuzumab for multiple sclerosis
- Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis (RRMS): a network meta-analysis
- Laquinimod for multiple sclerosis
- Cladribine for people with multiple sclerosis
- Rituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review
- Natalizumab for relapsing remitting multiple sclerosis
- Dimethyl fumarate for multiple sclerosis: Cochrane systematic review
- Teriflunomide for multiple sclerosis
- Multiple sclerosis (MS)